Abstract
Daclizumab is a humanized monoclonal antibody that binds to the alpha-subunit (CD25) of the interleukin-2 receptor (IL-2R), thus blocking the formatio......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
